UniProtKB/Swiss-Prot O43868: Variant p.Ser75Arg

Sodium/nucleoside cotransporter 2
Gene: SLC28A2
Feedback?

Variant information Variant position:

75 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Arginine (R) at position 75 (S75R, p.Ser75Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and polar (S) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1060896 [ dbSNP | Ensembl ]

Sequence information Variant position:

75 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

658 The length of the canonical sequence.
Location on the sequence:

YQRRSRWPFSKARSFCKTHA S LFKKILLGLLCLAYAAYLLA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         YQRRSRWPFSKARSFCKTHASLFKKILLGLLCLAYAAYLLA

Mouse                         WSRRIFQPFTKARSFFERHAGLFRKILLGLLCLAYAAYFLA

Rat                           W-RRILQPFTKARSFYQRHAGLFKKILLGLLCLAYAAYLLA

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 658	Sodium/nucleoside cotransporter 2

Literature citations
Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.
Ritzel M.W.L.; Yao S.Y.M.; Ng A.M.L.; Mackey J.R.; Cass C.E.; Young J.D.;
Mol. Membr. Biol. 15:203-211(1998)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; FUNCTION; TRANSPORTER ACTIVITY; VARIANT ARG-75; Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.
Owen R.P.; Gray J.H.; Taylor T.R.; Carlson E.J.; Huang C.C.; Kawamoto M.; Johns S.J.; Stryke D.; Ferrin T.E.; Giacomini K.M.;
Pharmacogenet. Genomics 15:83-90(2005)
Cited for: VARIANTS LEU-22; ARG-75; TRP-163; THR-245; SER-355 AND PHE-462; Identification and functional analysis of variants in the human concentrative nucleoside transporter 2, hCNT2 (SLC28A2) in Chinese, Malays and Indians.
Li L.; Tan C.M.F.; Koo S.H.; Chong K.T.; Lee E.J.D.;
Pharmacogenet. Genomics 17:783-786(2007)
Cited for: VARIANTS PRO-12; LEU-22; ARG-75; HIS-142; TRP-163; ASP-172; LYS-385 AND THR-612;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.